Laboratorios Farmaceuticos Rovi Stock

Invest in stocks with eToro from 50 EUR

Detail	Data
Volume (24h):	150,238 shares
P/E Ratio:	18.10
Forward P/E:	17.84
EPS:	2.67 EUR
Forward EPS:	2.71 EUR
Number of Shares:	51,145,500 shares
Market Capitalization:	2,472,373,504.00 EUR

The interactive chart displays the price movement of Laboratorios Farmaceuticos Rovi shares and updates every 15 minutes. It shows both the current price and historical trends. The chart offers various time frames, including daily, weekly, or monthly views, as well as the entire trading history.

Disclaimer: The data provided is for informational purposes only. Despite our efforts to ensure accuracy, it may contain errors or be outdated. We strongly recommend verifying the data from other independent sources. No investment decisions should be made based on this information.

Dividend

The company Laboratorios Farmaceuticos Rovi pays a dividend of 1.1 EUR per share. The annual dividend yield is 2.28%. The average dividend yield over the last 5 years is 0.86%. The payout ratio is 41.34%. The last paid dividend was 1.1037 EUR, paid on 2024-07-08. The ex-dividend date, the date when shares trade without entitlement to the next dividend, is 2024-07-08.

Dividend	Value
Dividend Amount	The company Laboratorios Farmaceuticos Rovi pays a dividend of 1.1 EUR per share.
Annual Yield %:	2.28 %
Ex-dividend Date:	2024-07-08
5-Year Avg Yield %:	0.86 %
Payout Ratio:	41.34 %
Last Dividend Value:	1.1037 EUR
Last Dividend Date:	2024-07-08

Analyst Forecast

Most analysts have issued a buy recommendation for Laboratorios Farmaceuticos Rovi stock. The current number of analysts covering this company is 8. The highest target price is 92 EUR, while the lowest target price is 72.5 EUR. The median target valuation set by analysts is 78.3 EUR. These forecasts and recommendations provide insight into how analysts view the future stock performance of Laboratorios Farmaceuticos Rovi.

Analysts	Recommendation
Issued Recommendation:	According to our data, the recommendation for Laboratorios Farmaceuticos Rovi stock is: buy
Number of Analysts:	8
Highest Target Price:	92 EUR
Lowest Target Price:	72.5 EUR
Median Target Price:	78.3 EUR

Fundamental Indicators

Indicator	Data
Total Revenue:	763,748,992.00 EUR
Net Income:	136,880,992.00 EUR
Price-to-Book (P/B):	4.32
PEG Ratio:	/
Exchange:	MCE
Industry:	Biotechnology
Sector:	Healthcare
Number of Employees:	2137
Country:	Spain

Where to Buy Laboratorios Farmaceuticos Rovi Stock?

You can purchase Laboratorios Farmaceuticos Rovi stock on the MCE under the ticker symbol: ROVI.MC. Several stock brokers or banks offer trading services for these stocks. Popular stock brokers like XTB and eToro allow you to buy real stocks and ETFs with zero or minimal commissions. Banks usually charge higher fees. Remember, investing in stocks involves risks, so it's important to carefully consider your financial situation and investment goals.

*To verify the availability of specific stocks on the platform, it's a good idea to first open a free demo account. Not all stocks are available.

Real stocks and ETFs. Low minimum deposit, only 50 EUR. Option to copy trades. Advanced stock analysis and free education.

Trustpilot rating 4.4/5 Google play rating 4.2/5

Invest in Stocks with eToro

★★★★★ 5.0

Real stocks and ETFs + free demo account. Low fees + fast customer support. More than 5,200 instruments available for trading. Free training and education. Regular live streams on YouTube.

Trustpilot rating 3.6/5 Google play rating 4.5/5

Try Free Demo Account

★★★★☆ 4.8

Risk warning: Trading CFDs involves a high risk of financial loss. Between 51%-eToro -89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

More Information on Laboratorios Farmaceuticos Rovi Stock

Indicator	Value
Company Revenue:	763,748,992.00 EUR
EBITDA:	199,615,008.00 EUR - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization.
Earnings Per Share:	2.67 EUR
Book Value Per Share:	11.18 EUR
Total Cash:	28,016,000.00 EUR
Total Cash per Share:	0.55 EUR
Total Debt:	114,410,000.00 EUR
Debt to Equity Ratio:	0.20
Quick Ratio	0.99
Current Ratio	3.13
Free Cash Flow	44,625,876.00 EUR
Operating Cash Flow	138,278,000.00 EUR
Gross Margins	61.24 %
EBITDA Margins	26.14 %
Operating Margins	16.25 %
Profit Margins	17.92 %
Return on Assets	13.7 %
Return on Equity	24.3 %
Earnings Growth (1 year)	-54.0%
Revenue Growth (1 year)	-15.1 %
Quarterly Earnings Year-over-Year Growth	-54.6 %
Market Capitalization	2,472,373,504.00 EUR
Enterprise Value	2,568,472,832.00 EUR
EV/Revenue	3.363
EV/EBITDA	12.867
Float Shares	18,746,291 shares
Shares Outstanding	51,145,500 shares
Held Percent Insiders	0.63 %
Held Percent Institutions	19.72 %
Shares Short	-
Shares Short Prior Month	-
Date Short Interest	-
Short Percentage of Total Shares	-
Short Ratio	-
Beta	0.47
Short Percentage of Float	-
Implied Shares Outstanding	53,365,400

Frequently Asked Questions (FAQ)

1️⃣ Does Laboratorios Farmaceuticos Rovi pay dividends?

The company Laboratorios Farmaceuticos Rovi pays a dividend of 1.1 EUR per share. At this rate, the annual yield is 2.28 %.

2️⃣ Where to buy Laboratorios Farmaceuticos Rovi shares?

Laboratorios Farmaceuticos Rovi shares are traded on the MCE stock exchange under the ticker: ROVI.MC. You can buy or trade them through a variety of stock brokers who provide real stock trading services.

3️⃣ What is the forecast for Laboratorios Farmaceuticos Rovi shares?

According to our data, the recommendation for Laboratorios Farmaceuticos Rovi shares is from a total of 8 analysts. The average target price prediction is 78.3 EUR per share.

4️⃣ What is the total number of shares and the value of Laboratorios Farmaceuticos Rovi on the stock exchange?

The total number of Laboratorios Farmaceuticos Rovi shares on the exchange is 51,145,500.00 shares, which at the current market capitalization gives the company a total valuation of 2,472,373,504.00 EUR.